Sustained β-catenin activation via GSK3 inhibition promotes direct fibroblast-to-cardiomyocyte reprogramming
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2026.111458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Xinghua Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, North Carolina, U…. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3, Myocytes, Cardiac, Fibroblasts, beta Catenin. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute Division of Intramural Research, National Institutes of Health.
Abstract (Originalsprache)
During iPSC differentiation, cardiomyocyte formation requires transient activation of canonical Wnt/β-catenin signaling followed by pathway inhibition. Inspired by the mechanisms governing iPSC differentiation into cardiomyocytes, this study sought to explore whether these pathways similarly affect direct fibroblast-to-cardiomyocyte reprogramming. In contrast to iPSC differentiation, direct reprogramming required early inhibition of glycogen synthase kinase-3 (GSK3), which leads to activation of β-catenin signaling, without a subsequent requirement for pathway suppression. Pharmacological GSK3 inhibition enhanced cardiomyocyte yield and improved functional maturation, as demonstrated by optical calcium mapping. Reporter assays confirmed increased β-catenin transcriptional activity, while non-canonical Wnt signaling was unaffected. Transcriptomic analysis revealed enhanced enrichment of muscle-associated gene ontology terms and modulation of immune and signaling pathways following GSK3 inhibition. Together, these findings suggest that although indirect and direct cardiac reprogramming share elements of Wnt pathway involvement, their temporal and mechanistic requirements differ substantially.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, North Carolina, USA.
- Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, North Carolina, USA. Electronic address: conrad.hodgkinson@duke.edu.
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute Division of Intramural Research
- National Institutes of Health
- Edna and Fred L Mandel Jr Foundation
Zitieren
APA
Wang, X., Anwar, I., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2026). Sustained β-catenin activation via GSK3 inhibition promotes direct fibroblast-to-cardiomyocyte reprogramming. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111458
Vancouver
Wang X, Anwar I, Pratt RE, Dzau VJ, Hodgkinson CP. Sustained β-catenin activation via GSK3 inhibition promotes direct fibroblast-to-cardiomyocyte reprogramming. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111458
BibTeX
@article{Wang2026,
author = {Wang, Xinghua and Anwar, Iqra and Pratt, Richard E and Dzau, Victor J and Hodgkinson, Conrad P},
title = {Sustained β-catenin activation via GSK3 inhibition promotes direct fibroblast-to-cardiomyocyte reprogramming},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2026.111458}
}
EUVIMED